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Abstract
Background: We reported that zinc neurotoxicity, a key mechanism of ischemic neuronal death, was mediated
by poly ADP-ribose polymerase (PARP) over-activation following NAD+/ATP depletion in cortical cultures. Because
AMP-activated protein kinase (AMPK) can be activated by ATP depletion, and AMPK plays a key role in excitotoxicity
and ischemic neuronal death, we examined whether AMPK could be involved in zinc neurotoxicity in mouse
cortical neuronal cultures.
Results: Compound C, an AMPK inhibitor, significantly attenuated zinc-induced neuronal death. Activation of
AMPK was detected beginning 2 h after a 10-min exposure of mouse cortical neurons to 300 μM zinc, although a
significant change in AMP level was not detected until 4 h after zinc treatment. Thus, AMPK activation might not
have been induced by an increase in intracellular AMP in zinc neurotoxicity. Furthermore, we observed that liver
kinase B1 (LKB1) but not Ca2+/calmodulin-dependent protein kinase kinase β (CaMKKβ), was involved in AMPK
activation. Although STO-609, a chemical inhibitor of CaMKKβ, significantly attenuated zinc neurotoxicity, zinc-induced
AMPK activation was not affected, which suggested that CaMKKβ was not involved in AMPK activation. Knockdown of
LKB1 by siRNA significantly reduced zinc neurotoxicity, as well as zinc-induced AMPK activation, which indicated a
possible role for LKB1 as an upstream kinase for AMPK activation. In addition, mRNA and protein levels of Bim, a
pro-apoptotic Bcl-2 family member, were noticeably increased by zinc in an AMPK-dependent manner. Finally,
caspase-3 activation in zinc-induced neuronal death was mediated by LKB1 and AMPK activation.
Conclusions: The results suggested that AMPK mediated zinc-induced neuronal death via up-regulation of Bim
and activation of caspase-3. Rapid activation of AMPK was detected after exposure of cortical neuronal cultures to
zinc, which was induced by LKB1 activation but not increased intracellular AMP levels or CaMKKβ activation.
Hence, blockade of AMPK in the brain may protect against zinc neurotoxicity, which is likely to occur after acute
brain injury.
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Background
Zinc serves as a component of zinc finger proteins and
DNA-binding proteins that are important for the regula-
tion of genes [1] and enzyme activity in all cells [2]. Like
other tissues, the brain has high levels of intracellular
zinc, but free zinc levels in the cytoplasm are very low
because most zinc ions are tightly bound to macromole-
cules, such as proteins and nucleic acids [3–5]. Further-
more, the brain has an additional pool of free zinc in a
subset of synaptic vesicles [6]. Although the function of
synaptic zinc is still under investigation, recent evidence
suggests that synaptic zinc is released into the synaptic
cleft where it induces synaptic activity [7–9]. However,
during acute brain injury caused by stroke, epilepsy, or
brain trauma, an excess amount of zinc is released, which
enters into post-synaptic neurons via calcium perme-
able routes, and leads to neuronal cell death [3, 10]. In
addition, oxidative stress may increase intracellular free
zinc by inducing release from intracellular stores such
as lysosomes, and from zinc-bound proteins such as
metallothioneins, leading to neuronal death [11, 12].
Many key players, such as PKC, NADPH oxidase, nNOS,
PARP, and caspase are involved in zinc-induced neuronal
death [13–16], and processes such as oxidative stress,
necrosis [17, 18], apoptosis [18–20], and lysosomal
membrane permeabilization (LMP) [21] are related to
zinc neurotoxicity.
AMP-activated protein kinase (AMPK), a serine/threo-
nine kinase, is critical for the homeostasis of cellular energy
in most eukaryotic tissues. Diverse physiological stressors
induce ATP consumption that leads to an increase in
the intracellular AMP/ATP ratio, which results in in-
creased AMPK activity [22, 23]. Activated AMPK in-
hibits energy-consuming biosynthetic pathways, such
as gluconeogenesis, fatty acid synthesis, protein synthe-
sis, and cell proliferation, which are necessary to main-
tain energy homeostasis [22–24].
Functional AMPK is a hetero-trimeric complex that
consists of a catalytic subunit (α) and two regulatory
subunits (β and γ). Several isomers of each subunit
have been reported (α1, α2; β1, β2; γ1, γ2, γ3) [22, 23].
The α-subunit has a kinase domain that can be phos-
phorylated by AMPK kinase itself, which increases its
enzymatic activity, whereas regulatory subunits simply
facilitate the phosphorylation or dephosphorylation of
the catalytic subunit via conformational change [22, 23].
There are two well-known upstream AMPK kinases:
liver kinase B1 (LKB1; also known as serine/threonine
kinase 11 [STK11]) and Ca2+/calmodulin-dependent
protein kinase kinase β (CaMKK β) [24–26]. Although
the mechanisms of activation of these two kinases are
different, LKB1 controls phosphorylation through the
AMP-mediated pathway, whereas CaMKK β controls
the Ca2+-mediated pathway [23–25]; LKB1 and CaMKK β
work together to activate AMPK [25]. In addition, LKB1 is
expressed in nearly every tissue [24, 27] and its deletion
results in considerable, albeit incomplete, inhibition of
AMPK activity [28]. CaMKK β functions in specific tissues
such as neurons [29], T-cells [30], and endothelial cells
[31]. The functional LKB1 complex, which consists of
LKB1 and two accessory subunits (STRAD and MO25),
phosphorylate threonine 172 (T172) of AMPK. Thus,
modulation of the LKB1-STRAD-MO25 complex regu-
lates AMPK activity via differential accessibility to phos-
phatase activity [22, 23, 25], which indicates that LKB1
complex acts as a master upstream kinase for AMPK [25].
Because AMPK is an energy sensor, and energy deple-
tion can lead to ischemic stroke, several studies have
examined the involvement of AMPK in brain ischemia.
In fact, numerous studies showed that over-activation of
AMPK mediated ischemic brain injury [26, 32–34]. In
addition, brain ischemia was shown to result in neuronal
cell death through necrosis and apoptosis [18], which
are processes that require ATP [35]; inhibition of AMPK
activity attenuated neuronal cell death [33]. Some in vivo
studies demonstrated that deletion of AMPK α2, but not
α1, was protective against ischemic brain injury [32, 33];
a similar result was reported for the heart [28], which
suggested a deleterious role for AMPK α2 in ischemic
stroke. Moreover, Concannon et al. [36] showed that
excitotoxicity via N-methyl-D-aspartic acid (NMDA) re-
ceptors led to neuronal cell death by disruption of ion
homeostasis, which was mediated by over-activation of
AMPK and induction of the pro-apoptotic Bcl-2 hom-
ology domain 3 (BH3)-only protein, Bim [27].
Our previous study has shown that during zinc-induced
neuronal death, over-activation of poly(ADP-ribose)
polymerase-1 (PARP-1) almost completely consumed
the intracellular pool of NAD+/ATP [16], which trig-
gered AMPK activation in zinc neurotoxicity. Therefore,
in the present study, we examined whether AMPK played
a critical role in zinc neurotoxicity, and which upstream
and downstream signaling molecules were involved in
AMPK-mediated zinc neurotoxicity.
Results
AMPK activation was involved in zinc neurotoxicity
Studies have shown that AMPK was involved in cytotox-
icity or cell death [26, 36–39], although contrary opin-
ions exist [26, 40]. Several research groups showed that
excitotoxicity or ischemic brain injury in a rat model
was significantly attenuated by inhibition of AMPK ac-
tivity [34, 36, 41, 42], which suggested a role for AMPK
in neurotoxicity. Many research groups have determined
that zinc-induced neuronal death is one neurotoxic mech-
anism that underlies ischemic brain injury [10, 43–48];
therefore, we investigated the involvement of AMPK in
zinc-induced neuronal death. Nearly-pure mouse neuronal
Eom et al. Molecular Brain  (2016) 9:14 Page 2 of 13
cultures were exposed to zinc (300 μM for 10 min) along
with the selective AMPK inhibitor, compound C (20 μM)
or the AMPK activator, metformin (50 μM). Here, we ob-
served significantly fewer TUNEL-positive cells (P < 0.05)
(Fig. 1a, indicated by arrow) in samples treated with the
AMPK inhibitor, compound C, compared to samples
treated with zinc alone. Conversely, samples treated
with the AMPK activator, metformin, had a signifi-
cantly increased number of apoptotic cells (P < 0.01)
(Fig. 1a). LDH release, a consequence of cell death, was
significantly decreased by compound C (P < 0.05) but
increased by metformin (P < 0.05) (Fig. 1b). These find-
ings suggested the involvement of AMPK activation in
zinc-mediated neurotoxicity.
Zinc-induced AMPK activation was not mediated by
increased intracellular AMP level
Because we observed that AMPK activation was re-
quired for zinc neurotoxicity, we examined whether the
phosphorylation of AMPK was induced by zinc in near-
pure cortical cultures. The major phosphorylation site of
AMPK, threonine 183/172 (T183 in AMPK α-1 or T172
in AMPK α-2), and an additional candidate site, serine
485/491 (S485 in AMPK α-1 or S491 in AMPK α-2)
[49], were targeted by western blotting. We detected
clear phosphorylation on T183/172 beginning 2 h after
zinc treatment (300 μM for 10 min), whereas we ob-
served no measurable phosphorylation on S485 or S491
(Fig. 2a). In addition, we found a zinc-triggered increase
of expression levels for both AMPK α-1 and α-2 (Fig. 2a)
from a very early time point, 30 min, after zinc treatment.
Previously, we showed that zinc-induced neuronal
death was mediated by NAD+/ATP depletion in con-
text of PARP over-activation [16]. Thus, we analyzed
changes in the intracellular AMP/ATP ratio as a trigger
for AMPK activation using a time-course experiment
in near-pure neuronal cultures exposed to zinc. Inter-
estingly, we found that zinc-induced AMPK activation
was not triggered by the increase of intracellular AMP
levels, because the AMP/ATP ratio increased signifi-
cantly beginning at 4 h post zinc treatment, which
reflected either significant ATP depletion or significant
AMP increase (P < 0.01) (Fig. 2b) compared to AMPK
activation beginning 2 h after zinc treatment (Fig. 2a).
Fig. 1 Requirement for AMPK in zinc neurotoxicity. a Microscopic images of Hoechst 33342-stained total nuclei (upper) or TUNEL-positive apoptotic
nuclei (lower) of the same field in mouse cortical near-pure neuronal cultures at 12 h after 10 min exposure to 300 μM zinc with or without
20 μM Compound C (CC) or 50 μM metformin (Met). Arrows indicate apoptotic shrunk and fragmented nuclei. Scale bar, 25 μm. b Quantitative
data for TUNEL-positive apoptotic cells (left, mean ± SEM, n= 3 cultures) or LDH release (right, mean ± SEM, n = 4 cultures) in near-pure neuronal cultures
after 12 h exposure of 300 μM zinc for 10 min with or without CC or Met, or metformin alone. *p < 0.05 and **p < 0.01 compared to zinc-exposed
cultures, two-tailed t-test
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It is generally acknowledged that AMPK senses the
intracellular AMP/ATP ratio and then is activated by
an increase of AMP/ATP ratio; therefore, these results
indicated that AMPK activation by zinc was independ-
ent from the intracellular AMP levels, and this activa-
tion might require another signaling modulator.
To begin, we tested whether zinc directly affected the
activation of AMPK. Zinc chloride was added directly to
purified, recombinant AMPK α-2, and then in vitro
AMPK activity was measured (Fig. 2c). The result of this
experiment showed that AMPK was not directly acti-
vated by zinc.
Next, we confirmed that PARP-1 over-activation was
involved in AMPK activation by zinc. The early activa-
tion of AMPK at 2 h after zinc treatment was not atten-
uated by nicotinamide (NAM), a chemical inhibitor of
PARP-1, which suggested that the initial phosphorylation
of AMPK in zinc-induced neuronal death was not medi-
ated by PARP-1. Taken together, these results indicated
that rapid activation of AMPK in zinc neurotoxicity was
Fig. 2 AMP-independent activation of AMPK in zinc neurotoxicity. a Representative western blot (left) and quantitation (right) results to document
phosphorylation of AMPK over the time-course of zinc treatment. Protein samples were prepared from near-pure neuronal cultures at the
indicated time points after 10 min exposure to 300 μM zinc. Actin was used as loading control. Graph data depict the mean ± SEM levels
of AMPK phosphorylation of threonine residues (T183 in α-1/T172 in α-2) normalized to actin and are expressed as a percent of control
levels (n = 3/group, *p < 0.05 compared to sham controls, two-tailed t-test). Whereas noticeable AMPK phosphorylation on serine residues
was not detected, AMPK phosphorylation on threonine residues (T183 in α-1/T172 in α-2) was detected beginning 2 h after zinc treatment.
b Intracellular AMP/ATP ratio over the time-course of zinc treatment (300 μM for 10 min). A significant increase in AMP/ATP ratio was detected beginning
4 h after zinc treatment. **p < 0.01 compared to sham controls, two-tailed t-test. c AMPK enzyme activity assay performed using recombinant
AMPK-α2 protein with or without zinc (1 μM) (mean ± SEM, n = 4). In vitro AMPK enzyme activity was not directly affected by zinc treatment.
d Representative western blots and quantitation of the phosphorylation of AMPK (n = 3/group). Protein samples were prepared from near-pure neuronal
cultures at 2 h after 300 μM zinc for 10 min with or without 2 mM nicotinamide (NAM), a chemical inhibitor of PARP. The activation of AMPK
at 2 h was not attenuated by NAM
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not induced by PARP-1 over-activation or intracellular
AMP/ATP ratio increase.
Identification of LKB1 as an upstream kinase for AMPK
activation in zinc neurotoxicity
Because we observed that an increase in the intracellular
AMP/ATP ratio was not the trigger for AMPK activation
in zinc neurotoxicity, we needed to identify, which up-
stream signaling molecules were involved in AMPK acti-
vation in zinc-induced neuronal death. LKB1 is a tumor
suppressor, often mutated in human Peutz-Jeghers syn-
drome, and a well-known upstream kinase of AMPK
[25, 50]. Because LKB1 directly phosphorylates AMPK
on T172 in an AMP-dependent manner [22, 25], we
examined the possibility that LKB1 mediated AMPK ac-
tivation after zinc treatment. Initially, we observed that
expression of LKB1 and phosphorylated LKB1 were
increased beginning 30 min after zinc treatment (Fig. 3a),
which correlated with a very early time point in com-
parison with AMPK activation at 2 h (Fig. 2a). In
addition, we observed that the level of phosphorylated
LKB1 returned to baseline at 4 h after zinc treatment,
while the expression level of LKB1 was sustained up to
4 h after zinc treatment (Fig. 3a).
Next, we examined whether LKB1 knockdown reduced
zinc-induced AMPK activation and neurotoxicity. In pri-
mary cortical neuronal cultures, the efficiency of trans-
fection with siRNA was very low; despite this problem,
we continued to use siRNA for LKB1 knockdown be-
cause there are no specific chemical inhibitors for LKB1.
Thus, three different sequences of LKB1 siRNA (#1, #2,
and #3) were transfected into near-pure neuronal cul-
tures, and then treated with zinc (300 μM for 10 min).
Although all three siRNAs significantly attenuated the
expression levels of LKB1 in mouse cortical neuronal
cultures (Fig. 3c), only one siRNA (LKB1 siRNA#1) sig-
nificantly reduced the number of TUNEL-positive apop-
totic nuclei (indicated by arrows) (P < 0.05) (Fig. 3b).
Consistent with this result, the levels of phosphorylated
AMPK were significantly decreased only by siRNA #1
(Fig. 3c). To confirm the effect of LKB1 knockdown on
zinc-mediated AMPK phosphorylation and neurotox-
icity, we next examined whether the introduction of the
active form of AMPK into LKB1 knockdown cells could
rescue the neuroprotective effects of LKB1 knockdown
on zinc-induced neuronal death. Confirming the possi-
bility of an LKB1-AMPK axis, neuroprotection by
siRNA #1 was completely reversed by co-transfection
with the active form of human AMPKα1 or AMPKα2,
and slight reduction of neuronal death by siRNA#3 was
also significantly diminished by co-expression of the active
form of AMPK (Fig. 3d). Collectively, these results sug-
gested that LKB1 was able to activate AMPK as an up-
stream signaling molecule in zinc neurotoxicity.
Many studies showing the LKB1-AMPK signaling path-
way have been reported, but the upstream regulatory
mechanism for LKB1 is not fully understood. LKB1 has
several autophosphorylation sites in the C-terminal
region, i.e., Ser31, Thr185, Thr189, Ser325, Thr336,
Thr363, Thr402, and Ser428 [51]. Among these, it has
been shown that Thr363 is phosphorylated by ATM in
response to ionizing radiation [52], and Ser428 is phos-
phorylated by cAMP-dependent kinase (PKA), p90RSK,
and protein kinase C zeta (PKCζ) [53–55]. Because we
previously reported that zinc-induced neuronal death
was mediated by PKC activation in mouse cortical cul-
tures [14, 16], we next tested the possibility that phos-
phorylation of LKB1 was mediated by PKC in zinc
neurotoxicity. Supporting the involvement of PKC in
LKB1 phosphorylation, zinc-induced LKB1 phosphoryl-
ation was almost completely attenuated by GF109203X,
a chemical inhibitor of PKC (Fig. 3e). Taken together,
rapid PKC activation by zinc may be an upstream signal
for LKB1 and AMPK activation in zinc-mediated neur-
onal death.
CaMKKβ was not an upstream kinase for zinc-induced
AMPK activation
CaMKKβ, which activates AMPK via a Ca2+-dependent
pathway, is another well-known upstream kinase of
AMPK [25, 56]. Treatment of near-pure neuronal cul-
tures with STO-609 (10 μM), a selective CaMKKβ
antagonist, significantly reduced zinc-induced neuronal
death (P < 0.05) (Fig. 4a). However, we confirmed by
western blotting that AMPK activation was not attenu-
ated by the CaMKKβ inhibitor (Fig. 4b). In fact, AMPK
phosphorylation was significantly increased by the inhib-
ition of CaMKKβ (Fig. 4b). Therefore, although CaMKKβ
may be involved in zinc neurotoxicity, AMPK activation
was not mediated by CaMKKβ in zinc neurotoxicity.
AMPK activation mediated the induction of Bim and the
resultant activation of caspase-3 in zinc neurotoxicity
Previously, another group showed that excitotoxicity was
mediated specifically by the induction of Bim expression
and resultant caspase-3 activation in an AMPK-dependent
manner [36]. Therefore, we examined whether the BH3-
only Bcl family was involved in AMPK-mediated zinc-
induced neuronal death. First, using reverse-transcription
(RT)-PCR, we observed that mRNA levels of bim and
puma were noticeably increased 3–4 h after zinc treat-
ment (Fig. 5a). In the case of noxa, mRNA levels were also
slightly augmented by zinc, but a significant increase was
not detected (Fig. 5a). However, western blot analysis
showed that the protein levels of Noxa as well as Bim and
PUMA were noticeably increased by zinc (Fig. 5b), sug-
gesting the possible activity of the BH3-only Bcl-2 family
in zinc-induced neuronal apoptosis. Consistently, clear
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Fig. 3 Possible role of LKB1 as an upstream kinase of AMPK in zinc neurotoxicity. a Representative western blots and quantitation of the
phosphorylation and expression of LKB1 over the time-course of zinc treatment (n = 3/group, *p < 0.05 compared to sham controls, two-tailed
t-test). Protein samples were prepared from zinc-treated (300 μM for 10 min), near-pure neuronal cultures at the indicated time points. b Microscopic
images (left) and quantitative data (right, mean ± SEM, n = 3 cultures) of Hoechst 33342-stained total nuclei (upper) and TUNEL-positive
apoptotic nuclei (lower) of the same field in mouse cortical near-pure neuronal cultures at 9 h after a 10-min exposure to 300 μM zinc with
or without siRNA knockdown with three different LKB1 siRNAs (#1, #2 or #3); scrambled siRNA was the negative control (NC). Arrows indicate apoptotic
nuclei. Scale bar, 25 μm. *p < 0.05 compared to zinc-exposed cultures, two-tailed t-test. c Representative western blots and quantitation of
the expression levels of LKB1 and phosphorylation of AMPK (n = 3/group, *p < 0.05 compared to zinc-exposed cultures). Near-pure cortical
neuronal cultures were transfected with siRNAs at DIV3 for 48 h, and then excess zinc was added (300 μM for 10 min). Protein samples were
prepared at 3 h after zinc treatment. d Quantitative data for TUNEL-positive apoptotic cells (mean ± SEM, n = 4 cultures) in mouse cortical near-pure
neuronal cultures at 9 h after a 10-min exposure to 300 μM zinc with or without siRNA alone or siRNA plus cDNA of active form of human AMPKα1 or
AMPK α2. Introduction of the active form of AMPKα1/α2 reversed neuroprotection by LKB1 siRNA #1 and significantly increased neuronal
death in LKB1 siRNA #3 knockdown condition. e Representative western blots and quantitation of phosphorylation and expression levels
of LKB1 (n = 3/group, *p < 0.05 compared to zinc-exposed cultures). Protein samples were prepared from cortical neuronal cultures at 0.5 h
after 300 μM zinc for 10 min with or without 5 μM GF109264X (GFX), a chemical inhibitor of PKC. The phophorylation and expression levels
of LKB1 induced by zinc were reversed by PKC inhibition
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activation of caspase-3 was observed 5 h after zinc ex-
posure (Fig. 5c). However, the increase in expression
among all members of the BH3-only Bcl-2 family may
not have been mediated by AMPK, because only Bim
was remarkably attenuated by compound C, a potent
AMPK inhibitor, and Noxa, and PUMA were not
(Fig. 5d). Furthermore, caspase-3 activation by zinc was
significantly blocked by Compound C, suggesting the
critical role of AMPK in caspase-3 activation by zinc
(Fig. 5e). We also observed a reduction of Bim expres-
sion and inhibition of caspase-3 by LKB1 siRNA #1
transfection of near-pure neuronal cultures (Fig. 5f ).
Consistent with the data showing cytotoxicity and
AMPK phosphorylation, only LKB1 siRNA #1, but not
siRNA #2 and #3, significantly attenuated the induction
of Bim and activation of caspase-3 (Fig. 5f ). Collect-
ively, these results strongly suggested that the induction
of Bim that was mediated by LKB1 and AMPK activa-
tion contributed to zinc-induced caspase-3 activation
and neurotoxicity.
Discussion
The main finding of this study was that the LKB1, AMPK,
and Bim signaling cascade contributed to zinc-induced
caspase-3 activation and neuronal death in mouse cortical
neuronal cultures. Although we observed that CaMKKβ
played a role in zinc neurotoxicity, CaMKKβ was not an
upstream kinase for AMPK activation in zinc-induced
neuronal death. Furthermore, neither over-activation of
PARP-1 nor increased intracellular AMP levels triggered
AMPK activation in zinc-induced neuronal death in mouse
cortical neuronal cultures.
Acute brain injury, including ischemic neuronal dam-
age, is related to diverse stressors, such as energy deple-
tion, hypoxia, oxidative stress, acidosis, and calcium and
zinc overload [57, 58]. In particular, loss of glucose and
oxygen supply alters the AMP/ATP balance, which leads
to the critical AMPK activation in the brain [34]. How-
ever, the overall consequence of AMPK activation seems
to be dependent upon the degree of AMPK activation,
cell types activated, and the metabolic status of cells and tis-
sues [41]. Some reports demonstrate that mild activation of
AMPK using a low dose of 5-Aminoimidazole-4-carboxa-
mide ribonucleotide (AICAR) attenuates hypoglycemic
stress and excitotoxicity in hippocampal neuronal cultures
[40] and ceramide-mediated-apoptosis in astrocyte cultures
[59]. In addition, the glucose and oxygen concentrations in
the culture conditions may alter the status of AMPK
activation and regulation [60, 61]. Under physiological
glucose (3 mM) and oxygen (5 %) culture conditions,
AMPK activation was reset at a new set point, which
could reproduce physiological conditions more closely
[62, 63]. More recently, other reports have shown the
detrimental role of AMPK activation in vitro in cell
lines and primary cortical neurons, and in vivo ischemic
injury animal models [34]. In support of these findings,
Fig. 4 CaMKKβ as an upstream kinase of AMPK was not involved in zinc neurotoxicity. a Microscopic images (left) and quantitative data (right,
mean ± SEM, n = 3 cultures) of Hoechst 33342-stained total nuclei (upper) and TUNEL-positive apoptotic nuclei (lower) of the same field in mouse
cortical near-pure neuronal cultures at 12 h after a 10-min exposure to 300 μM zinc with or without 10 μM STO-609 (STO), a CaMKKβ inhibitor.
Arrows indicate apoptotic nuclei. Scale bar, 25 μm. *p < 0.05 compared to zinc-exposed cultures, two-tailed t-test. Zinc-induced neuronal cell
death was markedly attenuated by STO. b Representative western blots and quantitation of phosphorylated AMPK (n= 3/group, *p< 0.05). Protein samples
were prepared from near-pure neuronal cultures at 4 h after 300 μM zinc treatment for 10 min with or without 10 μM STO-609. Phosphorylation of AMPK
was not reduced by STO-609
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AMPK α2 deletion but not AMPK α1 deletion in trans-
genic mice significantly reduced infarct volumes after
ischemic injury compared to wild-type mice [32]. In
another series of experiments, whereas compound C,
an AMPK inhibitor, attenuated infarct size and behav-
ioral defects of ischemic injury [33], metformin, an
anti-diabetic drug and AMPK activator, exacerbated
ischemic injury [64]. More interestingly, chronic met-
formin improved brain ischemic injury by reducing
AMPK activation [64], suggesting that the duration and
degree of AMPK activation are critical for cellular re-
sponses to ischemia. Although the exact mechanism
remains unclear, AMPK activation is detrimental in
stroke, and AMPK inhibition is neuroprotective.
Fig. 5 (See legend on next page.)
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Initially, AMPK was known to be activated by an ele-
vated AMP/ATP ratio and related stimuli including ex-
ercise, starvation, hypoxia, cellular pH, and redox status
[24]. However, many physiological and pathological con-
ditions that do not alter the AMP/ATP ratio modulate
AMPK signaling by direct or indirect effects on its kin-
ase activity [65]. Several upstream kinases, such as LKB1
and CaMKKβ, can activate AMPK via phosphorylation
at Thr183(α-1)/Thr172(α-2) of the catalytic α subunit
[24–26]. Here, we observed that initial activation of
AMPK at an early time point after zinc exposure of neu-
rons was not mediated by a change in intracellular
AMP/ATP ratio (Fig. 2). Instead, LKB1 activation and
induction were critical for AMPK activation. We ob-
served that phosphorylation of LKB1 was preceded by
phosphorylation of AMPK (Fig. 3a & Fig. 2a), and
showed that knockdown of LKB1 using siRNA notice-
ably attenuated AMPK activation (Fig. 3c) and zinc
neurotoxicity (Fig. 3b). Furthermore, the reduction of
zinc neurotoxicity by LKB1 siRNA #1 and #3 was almost
completely reversed by co-transfection of the active form
of AMPKα1 or AMPKα2 (Fig. 3d), confirming LKB1 as
the upstream kinase for AMPK. We also tested whether
CaMKKβ may be an upstream kinase for AMPK activa-
tion in zinc-induced neuronal death. Although chemical
inhibition of CaMKKβ by STO-609 significantly attenu-
ated zinc neurotoxicity, CaMKKβ did not appear to be
an upstream kinase for AMPK activation, because the
phosphorylation of AMPK was not affected by STO-609.
Previously, we demonstrated that zinc-induced neuronal
death shows apoptotic and necrotic aspects in cortical
cultures [18], and many compounds are involved in
zinc toxicity, including PKC, NADPH oxidase, nNOS,
PARP-1, ERK, and Egr-1 [13, 14, 16, 66]. Several re-
ports showed that PKCζ may be an upstream kinase for
LKB1 phosphorylation [51, 67] we also observed that
LKB1 phosphorylation by zinc could be mediated by
PKC, and showed that LKB1 phosphorylation was
almost completely attenuated by GF109203X, the spe-
cific chemical inhibitor of PKC, (Fig. 3e). However,
further studies are needed to clarify the signaling
cascade related to LKB1 and CaMKKβ action in zinc
neurotoxicity.
In addition to the phosphorylation of LKB1 and
AMPK, we observed elevated expression levels of LKB1
and AMPK in zinc-induced neuronal death. In the case
of AMPK, the clear increase of AMPK protein levels in-
duced by zinc was preceded by the phosphorylation of
AMPK (Figs. 2 and 3). Whereas the noticeable elevation
of AMPKα1 and AMPKα2 proteins was detected begin-
ning at 30 min after the exposure of neuronal cultures
to zinc, the significant increase of AMPK phosphoryl-
ation was observed beginning at 2 h after the onset of
zinc toxicity. Furthermore, the levels of AMPK and
phosphorylated AMPK proteins were regulated by
LKB1, because selective siRNAs for LKB1 almost com-
pletely reversed AMPK induction by zinc (Fig. 3c). In
the present study, we mainly focused on the phosphor-
ylation of LKB1 and AMPK; however, the regulation of
LKB1 and AMPK expression seemed to be crucial for
zinc-induced neuronal death. Metabolic stress, such as
high AMP levels, activates AMPK, and triggers phosphor-
ylation of the subfamily O of forkhead box transcription
factor 3 (FOXO3) at Ser413. Activated FOXO3 can bind
and activate its own gene promoter via a positive auto-
regulatory feedback loop, which results in the elevation of
FOXO3 transcription [68]. Enhanced FOXO3, in turn,
induces the master upstream kinase LKB1 that further
activates AMPK [68]. Thus, FOXO3 may act as a tran-
scription factor to induce and activate LKB1 and
AMPK under metabolic stress. In future studies, we will
examine the possibility that FOXO3 regulates de novo
synthesis of LKB1 or AMPK in zinc-induced neuronal
death.
Zinc-induced neuronal death has both necrotic and
apoptotic aspects in cortical neuronal cultures, depending
(See figure on previous page.)
Fig. 5 AMPK-mediated induction of Bim, and resultant activation of caspase-3 in zinc neurotoxicity. (a and b) RT-PCR (a) and western blots (b) to
measure the expression levels of Bim, Noxa, and Puma over the time-course of zinc treatment. mRNA and protein samples were prepared at the
indicated time points from sham-washed or zinc-treated near-pure neuronal cultures (300 μM for 10 min). Graphed data depict the mean ± SEM
levels of Bim/Noxa/PUMA normalized to actin at 4 h or 6 h after zinc treatment (n = 3/group, *p < 0.05 compared to sham control). Noticeable
increases in protein levels of Bim, Noxa, and PUMA were observed beginning 3–4 h after zinc treatment. cWestern blots for caspase-3 activation. Protein
samples were prepared at the indicated time points from near-pure neuronal cultures after zinc treatment. Caspase-3 activation by zinc was
clearly observed beginning 5 h after zinc treatment. (d and e) Representative western blots and quantitation of the expression of Bim, Noxa,
and Puma (d) and activation of caspase-3 (e) (n = 3/group, *p < 0.05 compared to zinc-exposed cultures). Protein samples were prepared from
near-pure neuronal cultures at 4 h for BH3-only Bcl-2 family proteins (d) or 5 h for caspase-3 activation (E) after 10-min exposure to 300 μM zinc with
or without 20 μM compound C (CC). Among the BH3-only Bcl-2 family, only the expression of Bim (induced by zinc treatment) was markedly
attenuated by Compound C. Caspase-3 activation was also reduced by Compound C in zinc-induced neuronal cell death. f Representative
western blots and quantitation of the expression of Bim and activation of caspase-3 (n = 3/group, *p < 0.05). Near-pure cortical neuronal cultures were
transfected with siRNAs for LKB1 at DIV3 for 48 h, followed by the addition of excess zinc (300 μM for 10 min). Protein samples were prepared at 4 h
after zinc treatment. LKB1 siRNAs #1 noticeably attenuated Bim induction and caspase-3 activation by zinc treatment
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on the duration of zinc exposure and magnitude of intra-
cellular zinc loading [18, 19]. Whereas a 10-min exposure
of mouse cortical neuron cultures to 400 μM zinc
showed more rapid necrosis (data not shown), exposure
of mouse cortical neuron cultures to 300 μM zinc for
10 min showed only a mild delay in apoptosis charac-
terized by cell shrinkage, and nuclear condensation and
fragmentation (Fig. 1a). Here, we used the apoptotic
zinc neurotoxicity model (300 μM zinc for 10 min), be-
cause the protective effect of compound C, an AMPK
inhibitor, was maximized in this model. Several studies
have demonstrated that the pro-apoptotic BH3-only pro-
teins of the Bcl-2 family were induced by AMPK activa-
tion in diverse apoptosis models [36, 69, 70]. Interestingly,
apoptosis of cerebellar granular neurons in response to
excitotoxicity was mediated by rapid AMPK activation
and resultant induction of the BH3-only protein Bim [36].
Hence, we examined the AMPK-mediated induction of
BH3-only proteins in zinc-induced caspase-3 activation
and neuronal death. Consistent with the hypothesis, the
noticeable increase in mRNA and protein levels of Bim-
EL, Bim-L, PUMA, and Noxa, and the slight elevation of
mRNA and protein levels of Bax were detected after the
zinc exposure of cortical neuronal cultures (Fig. 5a & b).
However, de novo synthesis of Bim but not PUMA, Noxa,
or Bax, was mediated only by AMPK and LKB1 in zinc-
induced cortical neuronal death (Fig. 5d & f). Recently,
it was reported that excitotoxicity activated the Bim pro-
moter in a FOXO3-dependent manner, which required
direct phosphorylation of FOXO3 by AMPK [69]. To
identify the upstream signaling cascade for other BH3-
only proteins including PUMA, Noxa, and Bax, other
transcription factors closely associated with apoptosis,
such as p53, should be evaluated in zinc-induced neuronal
death. As our understanding of AMPK regulation ex-
pands, our data reveal the tissue- and context-specific reg-
ulators that may be targeted for the development of new
drugs, or alternative therapies for the treatment of acute
brain injury.
Conclusions
We demonstrated the crucial role of AMPK in zinc-
triggered cortical neuronal death. LKB1 activation, rather
than increased AMP/ATP ratio or CaMKKβ activation,
triggered a rapid activation of AMPK, and resultant induc-
tion of the pro-apoptotic BH3-only protein, Bim. Finally,
caspase-3-mediated neuronal apoptosis was induced by
exposure to excessive zinc in mouse cortical neuronal
cultures. Because zinc neurotoxicity is likely a key com-
ponent in neuronal death related to acute brain injury,
the identification of this LKB1-AMPK-Bim signaling
cascade in zinc neurotoxicity is critical for the develop-
ment of new therapeutics for acute brain injury.
Methods
Mouse near-pure cortical neuronal cultures
Primary near-pure neuronal cultures were prepared
from embryonic mice at 13–14 days as described previ-
ously [18]. In brief, triturated cortical cells were seeded
onto a poly-D-lysine coated plate (SPL Life Sciences,
Gyeonggi-do, South Korea) at seven hemispheres per
24-well plate or nine hemispheres per 6-well plate, re-
spectively. Growth medium consisted of glutamine-free
Dulbecco’s modified Eagle medium (DMEM, GibcoBRL,
Grand Island, NY, USA) with 25 mM glucose, 44 mM so-
dium bicarbonate, 2 mM glutamine, 5 % fetal bovine
serum, and 5 % horse serum. For pure neuronal cell cul-
ture, 10 μM cytosine arabinoside (Sigma, St. Louis, MO,
USA) was added at days in vitro (DIV) 3. Cultures were
incubated at 37 °C in a humidified 5 % CO2 atmos-
phere. This procedure routinely produced near-pure
cortical neuronal cultures through DIV1 to DIV7 con-
sisting of > 96 % neurons, < 1 % astrocytes, and < 0.5 %
microglia. All experiments were performed at DIV 6–7.
The present study was conducted in accordance with
the guidelines for care and use of mice in research and
under protocols approved by the Animal Care and Use
Committee of The Sejong University.
Treatment with zinc and chemicals/drugs
Near-pure cortical neuronal cells were washed with
Eagle’s minimal essential medium (MEM, GibcoBRL)
and chemicals/drugs [Compound C (Dorsomorphin
dihydrochloride, Tocris, Bristol, UK), metformin (Sigma),
GF109203X (Sigma), or STO-609 (Sigma)] were added
30 min before zinc treatment. Near-pure cortical neuronal
cultures were treated with 300 μM zinc in Hank’s bal-
anced salt solution (HBSS, Welgene, Gyeongsangbuk-do,
South Korea) supplemented with 1.8 mM CaCl2, 1.22 μM
MgSO4, 3.15 μM MgCl2, and 1.94 mM glucose for
10 min. Subsequently, the zinc solution was replaced
by MEM and chemicals/drugs were replenished post-
treatment.
Estimation of cell death
Cell death was detected by terminal deoxynucleotidyl
transferase-mediated dUTP nick end labeling (TUNEL,
In Situ Cell Death Detection Kit, Fluorescein; Roche, In-
dianapolis, IN, USA) and 2 μg/ml Hoechst-33258 stain-
ing (Invitrogen, Carlsbad, CA, USA). Cultures were fixed
with 4 % paraformaldehyde for 15 min and then perme-
abilized with 0.1 % Triton X-100 for 10 min at room
temperature. TUNEL staining was performed according
to the manufacturer’s instructions and was followed by
Hoechst staining. Stained cells were analyzed using a
digital inverted fluorescence microscope (EVOS Cell Im-
aging System, Thermo Fisher, Waltham, MA, USA).
Quantitative TUNEL-positive cell counting data were
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based on the ratio of TUNEL-positive to Hoechst-positive
cells.
In addition, cell injury was measured by the level of
lactate dehydrogenase (LDH) released from the irrevers-
ibly damaged or dead cells into the medium [71]. LDH
values were normalized to the maximal LDH release
(=100 %) after 12 h exposure to 100 μM NMDA in sister
cultures.
Measurements of intracellular AMP and ATP levels
Cortical neuronal cultures were washed trice with cold
phosphate-buffered saline (PBS, Welgene) and lysed in
1.4 ml of cold methanol/H2O (80 % vol/vol) by vigorous
vortexing. The internal standard solution (100 μL of
5 μM glutamine-d4; Sigma) was added to the cell ex-
tracts. After centrifugation at 14,000 rpm for 10 min,
pellets were resuspended in RIPA lysis buffer [50 mM
Tris (pH 7.5), 150 mM NaCl, 1 % NP-40, 0.5 % deoxy-
cholic acid, 0.1 % SDS, and 5 mM EDTA with freshly
prepared protease/phosphatase inhibitors (2 μg/ml aproti-
nin, 2 μg/ml leupeptin, 1 μg/ml pepstatin A, 1 mM PMSF,
1 mM Na3VO4, 5 mM NaF, and 10 mM Na4P2O7)] and
the supernatant containing polar metabolites and lipids
was collected. Three ml of CHCl3/H2O (35 % vol/vol)
were added to the supernatant and the sample was mixed.
The upper aqueous layer (polar metabolites) and lower or-
ganic phases (lipids) were separated by centrifugation at
2,000 xg for 15 min. The organic phase was discarded and
the aqueous phase was extracted again with 1 ml of
CHCl3/H2O (50 % vol/vol) and then centrifuged at 2,000
xg for 15 min. The aqueous phase was collected and dried
using a vacuum centrifuge, and analyzed using liquid
chromatography-tandem mass spectrometry [LC-MS/MS;
1290 HPLC (Agilent Technologies, Palo Alto, CA, USA),
Qtrap 5500 (AB Sciex, Concord, Ontario, CAN) with a
reverse-phase column (Synergi fusion RP 50 × 2 mm,
Phenomenex, Torrance, CA, USA)] [72].
Measurement of in vitro AMPK enzyme activity
AMPK enzyme activity was measured using the CycLex
AMPK Kinase Assay Kit (MBL, Nagoya, Japan) and puri-
fied recombinant AMPK (A2/B1/G1, Active; MBL), as
described previously [73]. In brief, an IRS-1 S789
(AMPK α-2 substrate) pre-coated plate was incubated
with 3 ng of active AMPK enzyme with or without 1 μM
of zinc chloride in kinase reaction buffer supplemented
with 5 μM ATP (according to manufacturer’s protocol
for activator screening). To measure AMPK activity, the
amount of phosphorylated substrates was detected using
anti-phospho-mouse IRS-1 S789 monoclonal antibody
followed by horseradish peroxidase-conjugated anti-
mouse IgG. Color change was measured as absorbance
at 450 nm with a microplate reader (Molecular Devices,
Sunnyvale, CA, USA).
Reverse-transcription polymerase chain reaction (RT-PCR)
Total RNA from cortical neurons was isolated with Tri-
zol (Invitrogen). RNA (2 μg) was reverse transcribed to
cDNA and added to the PCR reaction mix (AccuPower
PCR premix kit, Bio-Rad, Hercules, CA, USA) according
to the manufacturer’s instructions. PCR was performed
with bim primers (5’-AGCCTGCTGAGAGGCCTCCC-
3’ and 5’-GATCCGCCGCAGCTCCTGTG-3’) or actin
primers (5’-TCTACAAATGTGGCTGAGGAC-3’ and 5’-
CCTGGGCCATTCAGAAATTA-3’) for 35 cycles (94 °C
for 1 min, 63 °C for 30 s, and 72 °C for 1 min), noxa
primers (5’-TTGCGCAGCCCGAGTCTTGG-3’ and 5’-
GGTTCACTGGCGCGTTCCGA-3’) for 34 cycles (94 °C
for 1 min, 60 °C for 1 min, and 72 °C for 1 min), or puma
primers (5’-CCGACCCTCACCCTGGAGGG-3’ and 5’-
AAGTCTCCGACGTCCCCCGG) for 30 cycles (95 °C for
1 min, 59 °C for 1 min, and 72 °C for 1 min). PCR prod-
ucts were electrophoresed on a 2 % agarose gel, stained
with ethidium bromide, and then visualized using (BIS
303 PC, DNR Bio-imaging Systems Ltd, Jerusalem, Israel).
Western blots
Cell lysates were prepared in RIPA lysis buffer contain-
ing 50 mM Tris (pH 7.5), 150 mM NaCl, 1 % NP-40,
0.5 % deoxycholic acid, 0.1 % SDS, and 5 mM EDTA
with freshly prepared protease/phosphatase inhibitors
(2 μg/ml aprotinin, 2 μg/ml leupeptin, 1 μg/ml pepsta-
tin A, 1 mM PMSF, 1 mM Na3VO4, 5 mM NaF, and
10 mM Na4P2O7). For western blotting of BH3-only Bcl
family proteins and caspase-3, a proteasome inhibitor
(10 μM MG-132, Sigma) was added to the protein ex-
tracts. Thirty micrograms of total protein were electro-
phoresed on 8 or 15 % polyacrylamide gels and then
transferred to PVDF membranes. Anti-phospho-AMPK
T183(α-1)/T172(α-2), phospho-AMPK S491(α-2), AMPK
α-1, AMPK α-2, Noxa, Puma (Abcam, Cambridge, UK),
phospho-AMPK S485(α-1), AMPK α, Bim, caspase-3,
cleaved-caspase-3, p-LKB1, or LKB1 (Cell Signaling
Technology, Danvers, MA, USA) antibodies were used.
Actin (Sigma) was used as the loading control. To
visualize the protein bands, enhanced chemilumines-
cence (iNTRoN Biotechnology, Gyeonggi-do, South
Korea) and a bio-imaging system (BIS 303 PC, Phile-
korea Technology, Daejeon, South Korea) were used.
Normalized band intensity was quantified using Image J
software.
Knockdown of LKB1 with siRNA and transfection with
cDNA of the active form of AMPKα1 or AMPKα2
Three different predesigned LKB1 (RNA accession
number NM_011492.1) siRNA oligonucleotides were
purchased from Bioneer (Daejeon, South Korea) (#1,
sense 5’- CGACAGAUUAGGCAGCACA-3’ and anti-
sense 5’-UGUGCUGCCUAAUCUGUCG-3’; #2, sense
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5’-CUCGUACCUAUCCCACCAA-3’ and antisense 5’-
UUGGUGGGAUAGGUACGAG-3’; #3, sense 5’- CCAC
CGAGGUAAUCUACCA-3’ and antisense 5’-UGGUA-
GAUUACCUCGGUGG-3’). Non-selective control siRNA
was obtained from Invitrogen (catalog number 45–2001).
cDNA of the active form of human AMPKα1 or AMPKα2
(Thr172 replaced with aspartic acid) was generously pro-
vided by Dr. Ha (Kyung Hee University, South Korea).
The transfection of siRNA into mouse cortical neuron
cultures was performed using Lipofectamine RNAi-
MAX (Invitrogen) at DIV 4 according to the manufac-
turer’s instructions. Lipofectamine 2000 (Invitrogen)
instead of RNAiMAX was used for cDNA transfection.
After 48 h incubation, zinc solution (300 μM for
10 min) was added to cortical neuronal cultures to in-
duce zinc neurotoxicity and AMPK activation.
Statistical analysis
A two-tailed t-test was used to determine statistically sig-
nificant differences between groups. Results are presented
as mean ± SEM. Statistically significant differences from
control are presented as *p < 0.05 and **p < 0.01.
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